Author: Kroesen, M.; Bull, C.; Gielen, P.R.; Brok, I.C.; Armandari, I.; Wassink, M.; Looman, M.W.G.; Boon, L.; den Brok, M.H.; Hoogerbrugge, P.M.; Adema, G.J.
Description: Neuroblastoma (NBL) is a childhood malignancy of the sympathetic nervous system. For high-risk NBL patients, the mortality rate is still over 50%, despite intensive multimodal treatment. Anti-GD2 monoclonal antibody (mAB) in combination with systemic cytokine immunotherapy has shown clinical efficacy in high-risk NBL patients. Targeted therapy using histone deacetylase inhibitors (HDACi) is currently being explored in cancer treatment and already shows promising results. Using our recently developed transplantable TH-MYCN NBL model, we here report that the HDAC inhibitor Vorinostat synergizes with anti-GD2 mAb therapy in reducing NBL tumor growth. Further mechanistic studies uncovered multiple mechanisms for the observed synergy, including Vorinostat-induced specific NBL cell death and upregulation of the tumor antigen GD2 on the cell surface of surviving NBL cells. Moreover, Vorinostat created a permissive tumor microenvironment (TME) for tumor-directed mAb therapy by increasing macrophage effector cells expressing high levels of Fc-receptors (FcR) and decreasing the number and function of myeloid-derived suppressor cells (MDSC). Collectively, these data imply further testing of other epigenetic modulators with immunotherapy and provide a strong basis for clinical testing of anti-GD2 plus Vorinostat combination therapy in NBL patients.
Subject Headings: Anti-gd2 mAb therapy; histone deacytelase inhibitor; immunotherapy; myeloid-derived suppressor cell; neuroblastoma
Keywords: Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma
Publication year: 2016
Journal or book title: Oncoimmunology
Volume: 5
Issue: 6
Pages: e1164919
Find the full text :Â https://scholar.google.com/scholar?output=instlink&q=info:t_N128wJURkJ:scholar.google.com/&hl=en&as_sdt=0,16&scillfp=11129775834801952886&oi=lle
Find more like this one (cited by): https://scholar.google.com/scholar?cites=1824250099521680311&as_sdt=1000005&sciodt=0,16&hl=en
Type: Journal Article
Serial number: 2569